drugset / Trial / NCT03601910
Clinical Study to Compare the Pharmacokinetic Characteristics and Safety Between CKD-380 10mg and D308 10mg
RandomizedCrossoverOpen-labelTreatment
Summary
This study is an open-label, randomized, fasted, single-dose, 2-way crossover study to compare the pharmacokinetic characteristics and safety between CKD-380 10mg and D308 10mg in healthy male adults.
Timeline
- Start
- 2018-07-16
- Primary completion
- 2018-09-21
- Completion
- 2018-11-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | D308 | Unknown | 10 mg | Oral |
| Subject | Dapagliflozin | Small molecule | 10 mg | Oral |